EQUITY PURCHASE AGREEMENT BY AND BETWEEN BIO-MATRIX SCIENTIFIC GROUP, INC. AND SOUTHRIDGE PARTNERS II, LP Dated April 23, 2012Equity Purchase Agreement • May 8th, 2012 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • New York
Contract Type FiledMay 8th, 2012 Company Industry JurisdictionTHIS EQUITY PURCHASE AGREEMENT entered into as of the 23st day of April, 2012 (this "AGREEMENT"), by and between SOUTHRIDGE PARTNERS II, LP, Delaware limited partnership ("INVESTOR"), and BIO-MATRIX SCIENTIFIC GROUP, INC., a Delaware corporation (the "COMPANY").
ContractUnit Purchase Agreement • December 27th, 2016 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledDecember 27th, 2016 Company Industry JurisdictionTHIS UNIT PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Regen Biopharma, Inc., a Nevada corporation (the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and __________( “Purchaser”), a _______ whose address is _____________.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 8th, 2012 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • New York
Contract Type FiledMay 8th, 2012 Company Industry JurisdictionThis Registration Rights Agreement ("Agreement"), dated April 23, 2012, is made by and between BIO-MATRIX SCIENTIFIC GROUP, INC. a Delaware corporation ("Company"), and SOUTHRIDGE PARTNERS II, LP, a Delaware limited partnership (the "Investor").
RIVULET MEDIA, INC. STOCK OPTION AGREEMENTStock Option Agreement • November 12th, 2020 • Rivulet Media, Inc. • Services-business services, nec • Delaware
Contract Type FiledNovember 12th, 2020 Company Industry JurisdictionRivulet Media, Inc. has granted to the individual (the “Participant”) named in the Notice of Grant of Stock Option (the “Notice”) to which this Stock Option Agreement (the “Option Agreement”) is attached an option (the “Option”) to purchase certain shares of Common Stock upon the terms and conditions set forth in the Notice and this Option Agreement. The Option has been granted pursuant to and shall in all respects be subject to the terms and conditions of the Rivulet Media, Inc. 2020 Equity Incentive Plan (the “Plan”), as amended to the Date of Option Grant, the provisions of which are incorporated herein by reference. By signing the Notice, the Participant: (a) represents that the Participant has received copies of, and has read and is familiar with the terms and conditions of, the Notice, the Plan, and this Option Agreement, (b) accepts the Option subject to all of the terms and conditions of the Notice, the Plan, and this Option Agreement, and (c) agrees to accept as binding, concl
EMPLOYMENT AGREEMENT BETWEEN REGEN BIOPHARMA, INC AND CHRISTINE ICHIMEmployment Agreement • January 22nd, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledJanuary 22nd, 2015 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of January 14, 2015 is entered into between Regen BioPharma, Inc., a Nevada corporation, (the "Company") and Christine Ichim ("Employee").
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC.License Agreement • June 26th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledJune 26th, 2015 Company Industry JurisdictionTHIS LICENSE AGREEMENT, including the exhibits referred to herein and attached hereto (the “Agreement”), effective as of June 23, 2015 (the “Effective Date”), is made and entered into by and between Regen BioPharma Inc., an Nevada corporation (“Licensor”) and Zander Therapeutics Inc., a Nevada corporation (“Licensee”). Licensor and Licensee may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”
UNIT PURCHASE AGREEMENT REGEN BIOPHARMA, INC.Unit Purchase Agreement • November 24th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledNovember 24th, 2015 Company Industry JurisdictionTHIS UNIT PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Regen Biopharma, Inc., a Nevada corporation (the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and __________( “Purchaser”), a _______ whose address is _____________.
EMPLOYMENT AGREEMENT BETWEEN REGEN BIOPHARMA, INC. AND TODD S. CAVENEmployment Agreement • February 13th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledFebruary 13th, 2015 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of February 11, 2015 is entered into between Regen BioPharma, Inc., a Nevada corporation, (the "Company") and Todd S. Caven ("Employee").
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND SANTOSH KESARIConsulting Agreement • August 11th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledAugust 11th, 2015 Company Industry JurisdictionAgreement by and between Santosh Kesari (“Consultant”) , a natural person whose address is at 3525 Del Mar Heights Road #133, San Diego CA 92130 and Regen Biopharma, Inc. (“Company”) , a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942.
AMENDMENT TO SUBLEASE AGREEMENT (“AGREEMENT”) ENTERED INTO OCTOBER 1, 2014 BY AND BETWEEN ENTEST BIOMEDICAL, INC. ( “SUBLESSOR”) AND REGEN BIOPHARMA,INC (“SUBTENANT”)Sublease Agreement • January 22nd, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec
Contract Type FiledJanuary 22nd, 2015 Company Industry
SUBLEASE AGREEMENTSublease Agreement • December 29th, 2014 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec
Contract Type FiledDecember 29th, 2014 Company IndustryThis is an agreement to sublet office space located at 4700 Spring Street, Suite 304, La Mesa, California 91942 according to the terms specified below.
PROMISSORY NOTEPromissory Note • January 31st, 2022 • Rivulet Media, Inc. • Services-business services, nec • Arizona
Contract Type FiledJanuary 31st, 2022 Company Industry JurisdictionFOR VALUE RECEIVED, RIVULET MEDIA, INC., a Delaware corporation with an address of 1206 E. Warner Rd, Suite 101-I, Gilbert, AZ 85296 (“Maker”), agrees and promises to pay to the order of ____________________ (“Holder”) or his designee, the sum of ____________________ ($__________).
EMPLOYMENT AGREEMENT BETWEEN REGEN BIOPHARMA, INC. ANDEmployment Agreement • October 13th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledOctober 13th, 2015 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of October 9, 2015 is entered into between Regen BioPharma, Inc., a Nevada corporation, (the "Company") and Harry M. Lander ("Employee").
WORLDWIDE INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT DATED May 1, 2013 This Intellectual Property Assignment Agreement (“Agreement”) is entered into on May 1, 2013 by and between Dr. Wei Ping Min (“Assignor”), an individual residing at 84 Hesketh St,...Intellectual Property Assignment Agreement • June 12th, 2013 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec
Contract Type FiledJune 12th, 2013 Company Industry
SUBSCRIPTION AGREEMENT RIVULET MEDIA, INC.Subscription Agreement • October 22nd, 2020 • Rivulet Media, Inc. • Services-business services, nec • Arizona
Contract Type FiledOctober 22nd, 2020 Company Industry JurisdictionThe undersigned (“Purchaser”) hereby subscribes to purchase the amount of Series A convertible promissory notes (“Notes”) of Rivulet Media, Inc., a Delaware corporation (the “Company”), set forth on the signature page hereof, with a minimum investment of $25,000. The Notes are convertible into shares of common stock of the Company (“Shares”) at the option of the Purchaser at a conversion price of $0.80 per Share and, should the closing price of the Shares as reflected on the OTC Market reach $1.20 or higher, shall automatically convert into the number of Shares that results by dividing the outstanding principal amount and all accrued but unpaid interest by $0.80. This subscription may be rejected by the Company in its sole discretion.
EMPLOYMENT AGREEMENT BETWEENEmployment Agreement • June 28th, 2012 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledJune 28th, 2012 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of June 15, 2012 is entered into between Bio-Matrix Scientific Group, Inc., a Delaware corporation, (the "Company") and Thomas Ichim ("Employee").
AMENDMENT TO LICENSE AGREEMENT DATED APRIL 6, 2015License Agreement • August 26th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec
Contract Type FiledAugust 26th, 2015 Company IndustryBenitec Australia Limited, an Australian corporation (ACN 080 299 645) having its registered office at 1-15 Barr Street, Balmain, NSW, Australia 2041, (“Benitec Australia”) and Regen BioPharma, Inc., a United States company having its registered office at 4700 Spring Street, Suite 304, La Mesa, CA 91942 USA, (“Regen BioPharma”)entered into a license agreement ( the “Agreement”) on August 5, 2013. Benitec Australia and Regen BioPharma may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”
LICENSE AGREEMENT - EXECUTIONLicense Agreement • August 6th, 2013 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • New South Wales
Contract Type FiledAugust 6th, 2013 Company Industry JurisdictionTHIS LICENSE AGREEMENT, including the exhibits referred to herein and attached hereto (the “Agreement”), effective as of August 5, 2013 (the “Effective Date”), is made and entered into by and between Benitec Australia Limited, an Australian corporation (ACN 080 299 645) having its registered office at 1-15 Barr Street, Balmain, NSW, Australia 2041, (“Benitec Australia”) and Regen BioPharma, Inc., a United States company having its registered office at 4700 Spring Street, Suite 304, La Mesa, CA 91942 USA, (“Regen BioPharma”). Benitec Australia and Regen BioPharma may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”
SERVICE AGREEMENTIndependent Contractor Agreement • October 1st, 2013 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledOctober 1st, 2013 Company Industry JurisdictionThis Independent Contractor Agreement (“Agreement”) is entered into this 27th day of July 2013 between Dr. Wei Ping Min (“Min”), a research scientist (hereinafter referred to as “Contractor”) whose address is 84 Hesketh Street, London Ontario N6G5H5, Canada and Regen BioPharma, Inc. (hereinafter referred to as “Client”), a Nevada corporation with offices at 4700 Spring Street, Suite 304, La Mesa, CA 91942.
EMPLOYMENT AGREEMENTEmployment Agreement • August 17th, 2020 • Rivulet Media, Inc. • Services-business services, nec • Arizona
Contract Type FiledAugust 17th, 2020 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (“Agreement”) is made in the State of Arizona by and between Michael J. Witherill (“Executive”) and Rivulet Media, Inc., a Delaware corporation (the “Company”).
July 1, 2016 David Koos Chairman & CEO Regen BioPharma Inc. (RGBP) La Mesa, CA 91942 Delivered: 07/01/2016 Via email to: David Koos david.koos@regenbiopharma.com Dear David,Investment Banking Engagement Agreement • July 7th, 2016 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec
Contract Type FiledJuly 7th, 2016 Company IndustryThe purpose of this investment banking engagement agreement (the "Agreement") is to set forth the terms and conditions pursuant to which CIM Securities, LLC ("CIM"), a FINRA member in good standing, shall act as exclusive financial advisor and placement agent for Regen BioPharma Inc. (RGBP, RGBPP) (“Company”), a Nevada Corporation and all affiliates (also the "Company") and introduce the Company to one or more accredited investors (“Investors”) in connection to a proposed private placement (the "Private Placement") of equity and / or debt securities (the "Securities") of the Company for the capital needed to continue research and development on four blocker compounds. However, CIM specifically acknowledges that the Company has retained Objective Capital Partners, located in San Diego, California, to identify potential strategic partners for the Company, which could result in an infusion of capital that does not involve the sale of debt or equity securities. The gross proceeds from the
EMPLOYMENT AGREEMENT BETWEEN ENTEST BIOMEDICAL, INC. AND DR. GREGORY MCDONALD, DVMEmployment Agreement • January 11th, 2011 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledJanuary 11th, 2011 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of December 31, 2010 is entered into between Entest BioMedical, Inc., a California corporation, (the "Company") and Dr. Gregory McDonald ("Employee").
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND THOMAS ICHIMConsulting Agreement • November 5th, 2015 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledNovember 5th, 2015 Company Industry JurisdictionAgreement made on November 2. 2015 by and between Thomas Ichim (“Consultant”) , a natural person whose address is at 9255 Towne Centre Drive #450 San Diego CA 91211 and Regen Biopharma, Inc. (“Company”) , a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. Consultant and Company may be referred to individually as “Party” and collectively as “Parties”.
ContractCollaboration Agreement • August 25th, 2009 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec
Contract Type FiledAugust 25th, 2009 Company IndustryAGREEMENT made this 18th day of August, 2009, by and between Therinject LLC, whose principal place of business is 10439 Roselle St Ste E hereinafter referred to as "Therinject", Steven Josephs, whose address is 1129 Rising Hill Way, Escondido, CA 92029 hereinafter referred to as “Josephs” and Bio-Matrix Scientific Group, Inc., whose principal place of business is 8885 Rehco Road, San Diego, California 92121, hereinafter referred to as "Company". Collectively, the Company, Therinject and Josephs may be referred to as the “Parties” or, singularly as “Party”
Exclusive License Agreement Between OHSU and Regen BioPharma, INC For Invention Disclosure 0472Exclusive License Agreement • June 12th, 2013 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • Oregon
Contract Type FiledJune 12th, 2013 Company Industry JurisdictionThis Exclusive License Agreement (this "Agreement"), dated and effective as of June 5, 2013 (the "Effective Date"), is between the Oregon Health & Science University, having offices at 0690 SW Bancroft Street, L106TT, Portland, Oregon 97239 ("OHSU"), and Regen BioPharma, Inc., having offices at 4700 Spring St # 304, La Mesa, CA 91942 ("Licensee"). OHSU and Licensee are herein referred to each as a "Party" and collectively as the "Parties."
Agreement made this 5th day of August 2016 by and between Regen Bioparma, Inc. (“Company) and David R. Koos (“Koos”)Employment Agreement • December 27th, 2016 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledDecember 27th, 2016 Company Industry JurisdictionWHEREAS, On February 13, 2015 Koos was issued Nine Million of the Company’s Common Shares (“Compensation Common Shares”) pursuant to that employment agreement entered into by and between Koos and the Company on February 11, 2015 ( “Employment Agreement”)
Consulting AgreementConsulting Agreement • December 29th, 2014 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledDecember 29th, 2014 Company Industry JurisdictionAgreement by and between Christine Ichim (“Consultant”) , a natural person whose address is at 12685 Campo Road, Spring Valley CA 91978 and Regen Biopharma, Inc. (“Company”) , a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • June 22nd, 2009 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledJune 22nd, 2009 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT (the “Agreement”) is entered into and is effective on this 16th day of June 2009 by and between JB Clothing Corporation, a Nevada corporation with principal address at 47 Fountainhead Circle, Henderson, Nevada 89052 (the “Buyer”), and Bio-Matrix Scientific Group, Inc., a Delaware corporation with principal address at 8885 Rehco Road, San Diego, California 92121 (the “Seller”). As used in this Agreement, the term, “Parties” shall refer to the Buyer and the Seller jointly.
SPECIAL ESCROW AGREEMENTSpecial Escrow Agreement • June 15th, 2006 • Tasco Holdings International, Inc. • Services-business services, nec • California
Contract Type FiledJune 15th, 2006 Company Industry JurisdictionThis Special Escrow Agreement (the "Escrow Agreement") is entered into as of June 9, 2006 by and between William M. Aul (the "Escrow Agent"), Bio-Matrix Scientific Group, Inc., a Delaware corporation (the “Seller”) and John Lauring (the “Stockholder”) herein collectively referred to herein as the “Parties” (“Parties”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • January 11th, 2011 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec
Contract Type FiledJanuary 11th, 2011 Company IndustryThis Asset Purchase Agreement ("AGREEMENT") is made as of December 17, 2010 by and among ENTEST BIOMEDICAL, INC., a California corporation (“Buyer”) which is wholly owned by ENTEST BIOMEDICAL INC., A Nevada corporation publicly traded on the OTC Bulletin Board under the symbol ENTB, PET POINTERS, INC., a California corporation ("Seller") doing business as McDonald Animal Hospital and DR. GREGORY MCDONALD, the sole shareholder, officer and director of the Seller (“Dr. Gregory McDonald” or “McDonald”).
Marketing Services AgreementMarketing Services Agreement • August 8th, 2007 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec
Contract Type FiledAugust 8th, 2007 Company IndustryThis Marketing Services Agreement (the “Agreement”) is entered into and is effective this 23 day of August 2005 by and between Bio-Matrix Scientific Group, Inc., a Delaware corporation with principal offices at 1010 University Avenue, Suite 40, San Diego, California 92108 (the “Company”), and Cord Blood America, Inc., a Florida corporation with principal offices at 9000 Sunset Boulevard, Suite 400, Los Angeles, California 90069 (“Marketer”). The term “Parties,” as used in this Agreement, shall jointly refer to the Company and Marketer.
Date: August 11, 2008Letter of Intent • August 19th, 2008 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec
Contract Type FiledAugust 19th, 2008 Company IndustryThis letter confirms our understanding of the mutual present intentions of Bio-Matrix Scientific Group, Inc. ("BMSN") and Cord Blood America ("CBAI") with respect to the principal terms and conditions under which BMSN shall provide storage and processing services to CBAI ("Transactions").
CONSULTING AGREEMENTConsulting Agreement • April 30th, 2009 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledApril 30th, 2009 Company Industry JurisdictionTHIS CONSULTING AGREEMENT ("Agreement") is made this 8th day of April, 2009, by and between Brian Koos, whose address is 27-139 CHS, 10833 Le Conte Avenue, Los Angeles, CA 90025-1740, hereinafter referred to as "CONSULTANT", and Bio-Matrix Scientific Group, Inc. , whose principal place of business is 8885 Rehco Road, San Diego, California 92121, hereinafter referred to as "Company".
WARRANT TO PURCHASE COMMON STOCKWarrant to Purchase Common Stock • August 28th, 2012 • Bio-Matrix Scientific Group, Inc. • Services-business services, nec • California
Contract Type FiledAugust 28th, 2012 Company Industry JurisdictionTHIS CERTIFIES THAT, for value received, Caven Investments, LLC, a Minnesota limited liability company or permitted assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Bio-Matrix Scientific Group, Inc., a Nevada corporation (the “Company”), up to sixteen million, five hundred thousand (16,500,000) shares of the Common Stock of the Company (the “Exercise Stock”).
SUBSCRIPTION AGREEMENT RIVULET MEDIA, INC.Subscription Agreement • January 4th, 2021 • Rivulet Media, Inc. • Services-business services, nec • Arizona
Contract Type FiledJanuary 4th, 2021 Company Industry JurisdictionThe undersigned (the “Purchaser”) hereby subscribes to purchase the number of shares of Common Stock, $0.0001 par value per share, of Rivulet Media, Inc., a Delaware corporation (the “Company”), set forth on the signature page hereof at a cash purchase price of $0.10 per share. The shares being purchased are referred to herein as the “Shares.” This subscription may be rejected by the Company in its sole discretion.